Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan.
Tsuzuki S, Hayakawa K, Doi Y, Shinozaki T, Uemura Y, Matsunaga N, Terada M, Suzuki S, Asai Y, Yamada G, Saito S, Shibata T, Kondo M, Izumi K, Hojo M, Mizoue T, Yokota K, Nakamura-Uchiyama F, Saito F, Sugiura W, Ohmagari N. Tsuzuki S, et al. Among authors: doi y. Infect Dis Ther. 2022 Jun;11(3):1075-1087. doi: 10.1007/s40121-022-00617-9. Epub 2022 Mar 21. Infect Dis Ther. 2022. PMID: 35307811 Free PMC article.
Correction for Miyoshi-Akiyama et al., "Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan".
Miyoshi-Akiyama T, Sherchan JB, Doi Y, Nagamatsu M, Sherchand JB, Tandukar S, Ohmagari N, Kirikae T, Ohara H, Hayakawa K. Miyoshi-Akiyama T, et al. Among authors: doi y. mSphere. 2017 May 24;2(3):e00136-17. doi: 10.1128/mSphere.00136-17. eCollection 2017 May-Jun. mSphere. 2017. PMID: 28567443 Free PMC article.
Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure.
Shindo Y, Kondoh Y, Kada A, Doi Y, Tomii K, Mukae H, Murata N, Imai R, Okamoto M, Yamano Y, Miyazaki Y, Shinoda M, Aso H, Izumi S, Ishii H, Ito R, Saito AM, Saito TI, Hasegawa Y. Shindo Y, et al. Among authors: doi y. Infect Dis Ther. 2021 Dec;10(4):2353-2369. doi: 10.1007/s40121-021-00512-9. Epub 2021 Aug 8. Infect Dis Ther. 2021. PMID: 34368914 Free PMC article.
Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect.
Ohno Y, Aoyagi K, Arakita K, Doi Y, Kondo M, Banno S, Kasahara K, Ogawa T, Kato H, Hase R, Kashizaki F, Nishi K, Kamio T, Mitamura K, Ikeda N, Nakagawa A, Fujisawa Y, Taniguchi A, Ikeda H, Hattori H, Murayama K, Toyama H. Ohno Y, et al. Among authors: doi y. Jpn J Radiol. 2022 Aug;40(8):800-813. doi: 10.1007/s11604-022-01270-5. Epub 2022 Apr 9. Jpn J Radiol. 2022. PMID: 35396667 Free PMC article. Clinical Trial.
Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function.
Hamada Y, Kasai H, Suzuki-Ito M, Matsumura Y, Doi Y, Hayakawa K. Hamada Y, et al. Among authors: doi y. Antibiotics (Basel). 2022 Mar 28;11(4):456. doi: 10.3390/antibiotics11040456. Antibiotics (Basel). 2022. PMID: 35453208 Free PMC article.
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part.
Mukae H, Yotsuyanagi H, Ohmagari N, Doi Y, Imamura T, Sonoyama T, Fukuhara T, Ichihashi G, Sanaki T, Baba K, Takeda Y, Tsuge Y, Uehara T. Mukae H, et al. Among authors: doi y. Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0069722. doi: 10.1128/aac.00697-22. Epub 2022 Sep 13. Antimicrob Agents Chemother. 2022. PMID: 36098519 Free PMC article. Clinical Trial.
Trends in antimicrobial-drug resistance in Japan.
Arakawa Y, Ike Y, Nagasawa M, Shibata N, Doi Y, Shibayama K, Yagi T, Kurata T. Arakawa Y, et al. Among authors: doi y. Emerg Infect Dis. 2000 Nov-Dec;6(6):572-5. doi: 10.3201/eid0606.000604. Emerg Infect Dis. 2000. PMID: 11076714 Free PMC article.
2,116 results